Sol 什么叫个股igenix公司介绍
| 证券代码： |
SNGX |
上市板： |
- |
| 证券名称： |
Soligenix |
上市场所： |
纳斯达克交易所 |
| 证券类型： |
- |
发行方式： |
- |
| 首发上市日： |
2016/12/13 |
首发价格(元)： |
- |
| 首发数量(股)： |
- |
首发募资总额(US 什么叫个股 什么叫个股d/元)： |
- |
Soligenix基本资料
| 公司名称： |
Soligenix, Inc. |
注册地址： |
Delaware |
| 证券名称： |
Soligenix |
上市场所： |
纳斯达克交易所 |
| 办公地址： |
29 Emmons Drive,Suite C-10,Princeton,NJ,08540 |
| 董事会主席： |
- |
成立日期： |
- |
| 公司属地： |
United States 美国 |
电话： |
1-609-538-8200 |
| 公司网址： |
www.soligenix.com |
| 公司介绍： |
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases primarily in the United States. It operates through two segments, BioTherapeutics and Vaccines/BioDefense. The BioTherapeutics segment develops SGX301, a photodynamic therapy, which is in Phase III clinical trial to treat cutaneous T-cell lymphoma; and proprietary formulations of oral beclomethasone 17,21-dipropionate for the prevention/treatment of gastrointestinal (GI) disorders characterized by severe inflammation, including pediatric Crohn’s disease and acute radiation enteritis. This segment also offers SGX942, a novel innate defense regulator technology that is in Phase II clinical trial to treat oral mucositis in head and neck cancer. The Vaccines/BioDefense segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has been completed Phase IB clinical trial for the treatment of vaccine against ricin toxin poisoning; VeloThrax, an anthrax vaccine candidate; OrbeShield, a GI acute radiation syndrome (GI ARS) therapeutic candidate, which is in pre-clinical stage to treat therapeutics against GI ARS; and SGX943, a melioidosis therapeutic candidate that is in pre-clinical stage for the treatment of melioidosis. These vaccines are supported by its ThermoVax, a heat stabilization technology. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in 2009. Soligenix, Inc. was founded in 1987 and is headquartered in Princeton, New Jersey. |
本文来自投稿，不代表本人立场，如若转载，请注明出处：http://www.smctrader.com/gushihangqing/61194.html
本站所有数据资料均来自第三方，仅作为用户获取信息，不构成投资建议，SMC股票学习网不为内容负责。
标签：
Soligenix股票代码
SNGX股票行情
Soligenix公司档案
Soligenix公司概况
SNGX基金净值
SNGX股票
SNGX股吧
SNGX